Table 5.
N | Tested n (%) | OR (95 % CI) | AORa (95 % CI) | |
---|---|---|---|---|
HIVb | 1122 | 746 (66.5) | 0.63 (0.44, 0.92)* | 0.62 (0.42, 0.90)* |
Chlamydia | 1240 | 593 (47.8) | 0.95 (0.67, 1.36) | 0.89 (0.62, 1.28) |
Gonorrhea | 1241 | 614 (49.5) | 0.94 (0.66, 1.34) | 0.91 (0.63, 1.30) |
Hepatitis A | 1240 | 542 (43.7) | 0.88 (0.62, 1.26) | 0.88 (0.61, 1.27) |
Hepatitis B | 1240 | 549 (44.3) | 0.92 (0.64, 1.31) | 0.92 (0.64, 1.32) |
Herpes | 1240 | 481 (38.8) | 1.00 (0.70, 1.44) | 0.95 (0.66, 1.38) |
HPV | 1240 | 472 (38.1) | 0.84 (0.58, 1.22) | 0.79 (0.54, 1.16) |
Syphilis | 1241 | 616 (49.6) | 0.94 (0.66, 1.33) | 0.92 (0.64, 1.32) |
For these analyses, valid is the reference group
Model adjusted for age and race/ethnicity
Individuals who reported being HIV-positive were not asked this question and are not included in this analysis
P < 0.05,
P < 0.01,
P < 0.001